Amantadine antagonism of oxotremorine effects
- 1 March 1979
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 46 (1) , 79-83
- https://doi.org/10.1007/bf01243431
Abstract
Summary Administration of oxotremorine to mice produced centrally-mediated effects, such as catalepsy and tremor, and peripheral muscarinic actions, such as diarrhoea and lachrymation. Pretreatment with amantadine (25–200 mg/kg) prevented these oxotremorine-induced effects in mice. Catalepsy was most susceptible and tremor most resistant to the administration of amantadine. The possible mechanisms involved are discussed. Our results validate the use of the oxotremorine model in the search for novel antiparkinsonian drugs.Keywords
This publication has 11 references indexed in Scilit:
- Abolition of oxotremorine effects by l-DOPA pretreatmentNeuropharmacology, 1979
- STUDIES ON THE MECHANISM OF ACTION OF AMANTADINEBritish Journal of Pharmacology, 1976
- Anticholinergic and membrane activities of amantadine in neuromuscular transmissionNature, 1976
- The mechanism of action of amantadine in Parkinsonism: a review.1975
- EFFECT OF AMANTADINE ON THE RATE OF DOPAMINE SYNTHESIS IN RAT CORPUS STRIATUM1Journal of Neurochemistry, 1975
- The effect of amantadine on motor activity and catalepsy in ratsPsychopharmacology, 1972
- Studies on the central effects of bulbocapninePsychopharmacology, 1971
- Antagonism by amantadine of prochlorpemazine-induced catalepsyJournal of Pharmacy and Pharmacology, 1970
- L-Dopa and ParkinsonismNature, 1970
- Anticataleptic actions of amantadine hydroehlorideNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1970